N-[3-(1H-Imidazol-4-ylmethyl)phenyl]ethanesulfonamide (ABT-866, 1), a Novel α1-Adrenoceptor Ligand with an Enhanced in Vitro and in Vivo Profile Relative to Phenylpropanolamine and Midodrine
- 22 August 2002
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 45 (20) , 4395-4397
Abstract
N-[3-(1H-Imidazol-4-ylmethyl)phenyl]ethanesulfonamide (ABT-866, 1) is a novel α1 agent having the unique profile of α1A (rabbit urethra, EC50 = 0.60 μM) agonism with α1B (rat spleen, pA2 = 5.4) and α1D (rat aorta, pA2 = 6.2) antagonism. An in vivo dog model showed 1 to be more selective for the urethra over the vasculature than A-61603 (2), ST-1059 (3, the active metabolite of midodrine), and phenylpropanolamine (4).Keywords
This publication has 15 references indexed in Scilit:
- COMPARISON OF α1-ADRENOCEPTOR AGONISTS IN CANINE URETHRAL PRESSURE PROFILOMETRY AND ABDOMINAL LEAK POINT PRESSURE MODELSJournal of Urology, 2001
- Vascular α1D-AdrenoceptorsArchives of Medical Research, 1999
- α1D‐Adrenoceptors contribute to the neurogenic vasopressor response in pithed ratsFundamental & Clinical Pharmacology, 1998
- Quantification and distribution of α1‐adrenoceptor subtype mRNAs in human proximal urethraBritish Journal of Pharmacology, 1998
- MidodrineDrugs & Aging, 1998
- α1-Adrenoceptor-induced contractility in rat aorta is mediated by the α1D subtypeEuropean Journal of Pharmacology, 1996
- Different α1-adrenoceptor subtypes mediate contraction in rabbit aorta and urethraEuropean Journal of Pharmacology, 1995
- A facile route to imidazol-4-yl anions and their reaction with carbonyl compoundsThe Journal of Organic Chemistry, 1991
- Phenylpropanolamine in treatment of female stress urinary incontinence Double-blind placebo controlled study in 24 patientsUrology, 1987
- The Effect of Midodrine and its Active Metabolite ST 1059 on the Human Urethra in vitro and in vivoScandinavian Journal of Urology and Nephrology, 1983